Literature DB >> 14746717

[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].

Stella M Macín1, Eduardo R Perna, Juan P Címbaro Canella, Pablo Alvarenga, Rolando Pantich, Nelson Ríos, Eduardo F Farías, Jorge R Badaracco.   

Abstract

OBJECTIVES: To compare the clinical characteristics and short- and long-term prognosis for chronic heart failure with left ventricular systolic dysfunction or preserved systolic function. PATIENTS AND
METHOD: Three-hundred twenty-eight consecutive patients with decompensated chronic heart failure were studied prospectively. Depending on ejection fraction, participants were classified as having systolic dysfunction (group 1, ejection fraction < or = 40%,) or preserved systolic function (group 2, ejection fraction >40%).
RESULTS: Systolic dysfunction was detected in 192 patients (58.5%) and preserved systolic function in 41.5%. Mean age was 62.7 (12.5 years) in group 1 and 65.2 (16.2 years) in group 2 (P=.03), with a male prevalence of 73.3% and 49.3%, respectively (P<.001). Ischemic cardiomyopathy was more frequent in group 1 (44.8% vs 25%; P<.001). Physical examination and electrocardiogram findings were similar in both groups, except for a higher proportion of patients in group 1 with a heart third sound (43.2% vs 25%; P=.001) and left bundle branch block (40.6% vs 15.4%; P<.001) and abnomal Q waves (31.3% vs 20.6%; P=.04). In-hospital mortality was similar in patients with systolic dysfunction and preserved systolic function (2.9% vs 1%; P=NS). Twenty-four-month cumulative survival was 61% for patients with systolic dysfunction and 76% for patients with preserved systolic function (log rank test P=NS). In the Cox proportional hazards model, which included age, sex, functional class, hepatomegaly, peripheral hypoperfusion, BUN, sodium level, ejection fraction > 40%, and biventricular heart failure, preserved systolic function was not associated with late mortality. The variables that were independent predictors of late mortality were peripheral hypoperfusion (OR = 3.7; P<.0001), low sodium level (OR=0.9; P=.009) and male sex (OR=1.9; P=.041).
CONCLUSIONS: Decompensated chronic heart failure with preserved systolic function was more frequent in women and older patients. Patients with preserved systolic function had a lower prevalence of coronary heart disease. However, these differences had no impact on the short- and long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14746717

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  6 in total

1.  Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease.

Authors:  Sanjiv J Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-01

2.  Prevalence and clinical outcome of main echocardiographic and hemodynamic heart failure phenotypes in a population of hospitalized patients 70 years old and older.

Authors:  Andrea Sonaglioni; Chiara Lonati; Lisa Tescaro; Gian Luigi Nicolosi; Marco Proietti; Michele Lombardo; Sergio Harari
Journal:  Aging Clin Exp Res       Date:  2022-01-06       Impact factor: 4.481

3.  Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study.

Authors:  Tamrat Befekadu Abebe; Eyob Alemayehu Gebreyohannes; Yonas Getaye Tefera; Tadesse Melaku Abegaz
Journal:  BMC Cardiovasc Disord       Date:  2016-11-21       Impact factor: 2.298

4.  Anemia in severe heart failure patients: does it predict prognosis?

Authors:  Tamrat Befekadu Abebe; Eyob Alemayehu Gebreyohannes; Akshaya Srikanth Bhagavathula; Yonas Getaye Tefera; Tadesse Melaku Abegaz
Journal:  BMC Cardiovasc Disord       Date:  2017-09-16       Impact factor: 2.298

5.  The prognosis of heart failure patients: Does sodium level play a significant role?

Authors:  Tamrat Befekadu Abebe; Eyob Alemayehu Gebreyohannes; Yonas Getaye Tefera; Akshaya Srikanth Bhagavathula; Daniel Asfaw Erku; Sewunet Admasu Belachew; Begashaw Melaku Gebresillassie; Tadesse Melaku Abegaz
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

6.  Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction.

Authors:  Bogdan Ioan Coculescu; Gabi Valeriu Dincă; Constantin Bălăeţ; Gheorghe Manole; Maria Bălăeţ; Cristina Mariana Stocheci
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.